Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR) (GENISPIRE)
Safety and Efficacy of Paclitax Drug Coated Balloon Catheter (Genoss® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study (GENISPIRE Registry)
Sponsor: Yonsei University
Listed as NCT05656118, this observational or N/A phase trial focuses on In-stent Restenosis and remains ongoing. Sponsored by Yonsei University, it has been updated 8 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting
-
Jun 2025 — Aug 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Apr 2025 — Jun 2025 [monthly]
Recruiting
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Recruiting
Status: Enrolling By Invitation → Recruiting
-
Jan 2023 — Apr 2024 [monthly]
Enrolling By Invitation
First recorded
Aug 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Yonsei University
For direct contact, visit the study record on ClinicalTrials.gov .